N. Sasso

Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.

D. Goldenberg, J. Siegel, R. Sharkey, 1990, Cancer research.

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide

A. Fiorentino, G. Lombardi, A. Surgo, 2021, Journal of personalized medicine.

Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas

A. Fiorentino, G. Lombardi, A. Surgo, 2022, Journal of personalized medicine.

Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).

D. Galetta, G. Colucci, E. Maiello, 2011, Clinical lung cancer.

[Abiraterone acetate: a novel therapeutic option in hormone-refractory prostate cancer].

N. Sasso, M. Di Bisceglie, G. Turitto, 2012, Recenti progressi in medicina.

Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma

A. Surgo, L. Laera, R. Carbonara, 2023, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].